Drug Profile
Research programme: high molecular weight polyethylene glycols - Midway
Alternative Names: MDY-1001; PEG 15-20 - MidwayLatest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator Midway Pharmaceuticals
- Class Polyethylene glycols; Polymers
- Mechanism of Action
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Radiation injuries
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in Radiation injuries (Prevention) in USA (PO)
- 04 Dec 2009 Preclinical trials in Radiation injuries (Prevention)/Radioprotection in USA (PO)